HotOtc Featured Company: CardioVascular BioTherapeutics, Inc. (CVBT.OB) Solid Results in Phase I – Permission Granted for Phase II
CardioVascular BioTherapeutics’ lead heart disease medication has been granted Phase II testing permission after solid results were found in Phase I trials. Phase II catheter and placebo tests promise to move this quality of life medication one step closer to final approvals. The bioscience company is involved in developing drug treatments designed to help people with critical heart disease issues. It is also involved in developing a drug treatment that helps with the healing process of wounds and lesions associated with diabetes. As with any bioscience company, getting the drug treatments through the testing and approvals process is the main…